Skip to main content
Top
Published in: Diabetologia 10/2012

Open Access 01-10-2012 | Article

Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes

Authors: G. Hindy, E. Sonestedt, U. Ericson, X.-J. Jing, Y. Zhou, O. Hansson, E. Renström, E. Wirfält, M. Orho-Melander

Published in: Diabetologia | Issue 10/2012

Login to get access

Abstract

Aims/hypothesis

The T allele of transcription factor 7-like 2 gene variant, TCF7L2 rs7903146, increases the risk of type 2 diabetes by 40–50%. As TCF7L2 rs7903146 has been associated with diminished incretin effect we investigated whether interaction between dietary intake of carbohydrate, fat, protein or fibre and this variant affects the risk of type 2 diabetes.

Methods

A cohort of 24,799 non-diabetic individuals from the Malmö Diet and Cancer Study (MDCS), with dietary data obtained by a modified diet history method, were followed up for 12 years, with 1,649 recordings of incident type 2 diabetes made. Risk of type 2 diabetes in strata of diet quintiles was analysed prospectively adjusting for potential confounders. Cross-sectional analyses were performed on baseline fasting glucose and HbA1c levels in a subset of 5,216 randomly selected individuals from the MDCS.

Results

The elevated risk of type 2 diabetes with rs7903146 (OR 1.44, 95% CI 1.33, 1.56, p = 4.6 × 10−19) increased with higher intake of dietary fibre (OR 1.24, 95% CI 1.04, 1.47 to OR 1.56, 95% CI 1.31, 1.86 from the lowest to highest quintile; p interaction = 0.049). High intake of dietary fibre was inversely associated with diabetes incidence only among CC genotype carriers (OR 0.74, 95% CI 0.58, 0.94 per quintile, p = 0.025). The T allele was associated with 0.027% elevated HbA1c (p = 0.02) and this effect increased with higher intake of fibre (from −0.021% to 0.079% for the lowest to the highest quintile, p interaction = 0.02). Each quintile of higher fibre intake was associated with lower HbA1c levels among CC and CT but not among TT genotype carriers (−0.036%, p = 6.5 × 10−7; −0.023%, p = 0.009; and 0.012%, p = 0.52, respectively).

Conclusions/interpretation

Our study suggests that dietary fibre intake may modify the association between TCF7L2 rs7903146 and incidence of type 2 diabetes, and that higher fibre intake may associate with protection from type 2 diabetes only among non-risk allele carriers.
Literature
1.
go back to reference Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323PubMedCrossRef Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323PubMedCrossRef
2.
go back to reference Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225PubMedCrossRef Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225PubMedCrossRef
3.
go back to reference Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116PubMedCrossRef Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116PubMedCrossRef
4.
go back to reference Franklin CS, Aulchenko YS, Huffman JE et al (2010) The TCF7L2 diabetes risk variant is associated with HbA(C) levels: a genome-wide association meta-analysis. Ann Hum Genet 74:471–478PubMedCrossRef Franklin CS, Aulchenko YS, Huffman JE et al (2010) The TCF7L2 diabetes risk variant is associated with HbA(C) levels: a genome-wide association meta-analysis. Ann Hum Genet 74:471–478PubMedCrossRef
5.
go back to reference Prunier C, Hocevar BA, Howe PH (2004) Wnt signaling: physiology and pathology. Growth Factors 22:141–150PubMedCrossRef Prunier C, Hocevar BA, Howe PH (2004) Wnt signaling: physiology and pathology. Growth Factors 22:141–150PubMedCrossRef
6.
go back to reference Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280:1457–1464PubMedCrossRef Yi F, Brubaker PL, Jin T (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280:1457–1464PubMedCrossRef
7.
go back to reference Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163PubMedCrossRef Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163PubMedCrossRef
8.
go back to reference Saxena R, Gianniny L, Burtt NP et al (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55:2890–2895PubMedCrossRef Saxena R, Gianniny L, Burtt NP et al (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55:2890–2895PubMedCrossRef
9.
go back to reference Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 138:159–166PubMedCrossRef Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 138:159–166PubMedCrossRef
10.
go back to reference Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, Goke B (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56:117–126PubMedCrossRef Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, Goke B (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56:117–126PubMedCrossRef
11.
go back to reference Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef
12.
go back to reference Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB (2009) Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 101:478–481PubMedCrossRef Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB (2009) Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 101:478–481PubMedCrossRef
13.
go back to reference Nettleton JA, McKeown NM, Kanoni S et al (2010) Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care 33:2684–2691PubMedCrossRef Nettleton JA, McKeown NM, Kanoni S et al (2010) Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care 33:2684–2691PubMedCrossRef
14.
go back to reference Cornelis MC, Qi L, Kraft P, Hu FB (2009) TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 89:1256–1262PubMedCrossRef Cornelis MC, Qi L, Kraft P, Hu FB (2009) TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 89:1256–1262PubMedCrossRef
15.
go back to reference Heni M, Herzberg-Schafer S, Machicao F, Haring HU, Fritsche A (2012) Dietary fiber intake modulates the association between variants in TCF7L2 and weight loss during a lifestyle intervention. Diabetes Care 35:e24PubMedCrossRef Heni M, Herzberg-Schafer S, Machicao F, Haring HU, Fritsche A (2012) Dietary fiber intake modulates the association between variants in TCF7L2 and weight loss during a lifestyle intervention. Diabetes Care 35:e24PubMedCrossRef
16.
go back to reference Manjer J, Carlsson S, Elmstahl S et al (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Canc Prev 10:489–499CrossRef Manjer J, Carlsson S, Elmstahl S et al (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Canc Prev 10:489–499CrossRef
17.
go back to reference Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjornsdottir S (2008) Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31:2038–2043PubMedCrossRef Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjornsdottir S (2008) Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31:2038–2043PubMedCrossRef
18.
go back to reference Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD (2001) Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17:983–989PubMedCrossRef Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD (2001) Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17:983–989PubMedCrossRef
19.
go back to reference Enhorning S, Wang TJ, Nilsson PM et al (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102–2108PubMedCrossRef Enhorning S, Wang TJ, Nilsson PM et al (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121:2102–2108PubMedCrossRef
20.
go back to reference Hanas R, John G (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33:1903–1904PubMedCrossRef Hanas R, John G (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care 33:1903–1904PubMedCrossRef
21.
go back to reference Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174PubMedCrossRef Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174PubMedCrossRef
22.
go back to reference Callmer E, Riboli E, Saracci R, Akesson B, Lindgarde F (1993) Dietary assessment methods evaluated in the Malmo food study. J Intern Med 233:53–57PubMedCrossRef Callmer E, Riboli E, Saracci R, Akesson B, Lindgarde F (1993) Dietary assessment methods evaluated in the Malmo food study. J Intern Med 233:53–57PubMedCrossRef
23.
go back to reference Wirfalt E, Mattisson I, Johansson U, Gullberg B, Wallstrom P, Berglund G (2002) A methodological report from the Malmo Diet and Cancer study: development and evaluation of altered routines in dietary data processing. Nutr J 1:3PubMedCrossRef Wirfalt E, Mattisson I, Johansson U, Gullberg B, Wallstrom P, Berglund G (2002) A methodological report from the Malmo Diet and Cancer study: development and evaluation of altered routines in dietary data processing. Nutr J 1:3PubMedCrossRef
24.
go back to reference Riboli E, Elmstahl S, Saracci R, Gullberg B, Lindgarde F (1997) The Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol 26(Suppl 1):S161–S173PubMedCrossRef Riboli E, Elmstahl S, Saracci R, Gullberg B, Lindgarde F (1997) The Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol 26(Suppl 1):S161–S173PubMedCrossRef
25.
go back to reference Mattisson I, Wirfalt E, Aronsson CA et al (2005) Misreporting of energy: prevalence, characteristics of misreporters and influence on observed risk estimates in the Malmo Diet and Cancer cohort. Br J Nutr 94:832–842PubMedCrossRef Mattisson I, Wirfalt E, Aronsson CA et al (2005) Misreporting of energy: prevalence, characteristics of misreporters and influence on observed risk estimates in the Malmo Diet and Cancer cohort. Br J Nutr 94:832–842PubMedCrossRef
26.
go back to reference Lyssenko V, Eliasson L, Kotova O et al (2011) Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes 60:2424–2433PubMedCrossRef Lyssenko V, Eliasson L, Kotova O et al (2011) Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes 60:2424–2433PubMedCrossRef
27.
go back to reference Gauderman WJ, and Morrison, JM (2006) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. Available from http://hydra.usc.edu/gxe/, accessed 1 March 2012 Gauderman WJ, and Morrison, JM (2006) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. Available from http://​hydra.​usc.​edu/​gxe/​, accessed 1 March 2012
28.
go back to reference Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR (2000) Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921–930PubMed Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, Folsom AR (2000) Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921–930PubMed
29.
go back to reference Wannamethee SG, Whincup PH, Thomas MC, Sattar N (2009) Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care 32:1823–1825PubMedCrossRef Wannamethee SG, Whincup PH, Thomas MC, Sattar N (2009) Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care 32:1823–1825PubMedCrossRef
30.
go back to reference Anderson JW (1986) Fiber and health: an overview. Am J Gastroenterol 81:892–897PubMed Anderson JW (1986) Fiber and health: an overview. Am J Gastroenterol 81:892–897PubMed
31.
go back to reference Adam TC, Westerterp-Plantenga MS (2005) Nutrient-stimulated GLP-1 release in normal-weight men and women. Horm Metab Res 37:111–117PubMedCrossRef Adam TC, Westerterp-Plantenga MS (2005) Nutrient-stimulated GLP-1 release in normal-weight men and women. Horm Metab Res 37:111–117PubMedCrossRef
32.
go back to reference Karhunen LJ, Juvonen KR, Flander SM et al (2010) A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr 140:737–744PubMedCrossRef Karhunen LJ, Juvonen KR, Flander SM et al (2010) A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr 140:737–744PubMedCrossRef
33.
go back to reference Freeland KR, Wilson C, Wolever TM (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103:82–90PubMedCrossRef Freeland KR, Wilson C, Wolever TM (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103:82–90PubMedCrossRef
34.
go back to reference Reimer RA, McBurney MI (1996) Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 137:3948–3956PubMedCrossRef Reimer RA, McBurney MI (1996) Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 137:3948–3956PubMedCrossRef
35.
go back to reference Tappenden KA, Thomson AB, Wild GE, McBurney MI (1996) Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr 20:357–362PubMedCrossRef Tappenden KA, Thomson AB, Wild GE, McBurney MI (1996) Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr 20:357–362PubMedCrossRef
36.
go back to reference Zhou J, Hegsted M, McCutcheon KL et al (2006) Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 14:683–689CrossRef Zhou J, Hegsted M, McCutcheon KL et al (2006) Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring) 14:683–689CrossRef
37.
go back to reference Nilsson AC, Ostman EM, Knudsen KE, Holst JJ, Bjorck IM (2010) A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J Nutr 140:1932–1936PubMedCrossRef Nilsson AC, Ostman EM, Knudsen KE, Holst JJ, Bjorck IM (2010) A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J Nutr 140:1932–1936PubMedCrossRef
38.
go back to reference Tarini J, Wolever TM (2010) The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35:9–16PubMedCrossRef Tarini J, Wolever TM (2010) The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35:9–16PubMedCrossRef
39.
go back to reference Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D (2008) Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19:587–593PubMedCrossRef Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D (2008) Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 19:587–593PubMedCrossRef
40.
go back to reference Gaulton KJ, Nammo T, Pasquali L et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255–259PubMedCrossRef Gaulton KJ, Nammo T, Pasquali L et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255–259PubMedCrossRef
41.
go back to reference Bordonaro M, Lazarova DL, Sartorelli AC (2007) The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res 313:1652–1666PubMedCrossRef Bordonaro M, Lazarova DL, Sartorelli AC (2007) The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res 313:1652–1666PubMedCrossRef
Metadata
Title
Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
Authors
G. Hindy
E. Sonestedt
U. Ericson
X.-J. Jing
Y. Zhou
O. Hansson
E. Renström
E. Wirfält
M. Orho-Melander
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2634-x

Other articles of this Issue 10/2012

Diabetologia 10/2012 Go to the issue